Impact of retroviral vector components stoichiometry on packaging cell lines: Effects on productivity and vector quality

Human Gene Therapy

Volumn 19, Issue 2, 2008, Pages 199-210

  Carrondo, Manuel J T ^a,b   Merten, Otto Wilhelm ^c   Haury, Matthias ^d,e   Alves, Paula M ^a   Coroadinha, Ana S ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c GÉNÉTHON   (France)

^d INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GENOMIC RNA; POL PROTEIN; RECOMBINASE; RETROVIRUS VECTOR; RNA;

ARTICLE; CELL LINE; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; STOICHIOMETRY;

BETA-GALACTOSIDASE; CELL LINE; CLONE CELLS; FUSION PROTEINS, GAG-POL; GENE THERAPY; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, GIBBON APE; ORGAN SPECIFICITY; RECOMBINATION, GENETIC; RETROVIRIDAE; RNA-DIRECTED DNA POLYMERASE; TRANSGENES; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS ASSEMBLY;

EID: 39449115121     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.0101     Document Type: Article

References (30)

1. ANDREADIS, S.T., ROTH, C.M., LE DOUX, J.M., MORGAN, J.R., and YARMUSH, M.L. (1999). Large-scale processing of recombinant retroviruses for gene therapy. Biotechnol. Prog. 15, 1-11.
2. ARAI, T., MATSUMOTO, K., SAITOH, K., UI, M., ITO, T., MURAKAMI, M., KANEGAE, Y., SAITO, I., COSSET, F.L., TAKEUCHI, Y., and IBA, H. (1998). A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J. Virol. 72, 1115-1121.
3. BAJGELMAN, M.C., COSTANZI-STRAUSS, E., and STRAUSS, B.E. (2003). Exploration of critical parameters for transient retrovirus production. J. Biotechnol. 103, 97-106.
4. CARMO, M., PEIXOTO, C., COROADINHA, A.S., ALVES, P.M., CRUZ, P.E., and CARRONDO, M.J. (2004). Quantitation of MLV-based retroviral vectors using real-time RT-PCR. J. Virol. Methods 119, 115-119.
5. COFFIN, J.M., HUGBES, S.H., and VARMUS, H.E. (1997). Retroviruses. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
6. COROADINHA, A.S., RIBEIRO, J., ROLDÃO, A., CRUZ, P.E., ALVES, P.M., MERTEN, O.-W., and CARRONDO, M.J.T. (2006a). Effect of medium sugar source on the production of retroviral vectors for gene therapy. Biotechnol. Bioeng. 94, 24-36.
7. COROADINHA, A.S., SCHUCHT, R., GAMA-NORTON, L., WIRTH, D., HAUSER, H., and CARRONDO, M.J.T. (2006b). The use of recombinase cassette exchange in retroviral vector producer cell lines: Predictability and efficiency in transgene exchange. J. Biotechnol. 124, 457-468.
8. COSSET, F.L., TAKEUCHI, Y., BATTINI, J.L., WEISS, R.A., and COLLINS, M.K. (1995). High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-7436.
9. DANOS, O., and MULLIGAN, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. U.S.A. 85, 6460-6464.
10. GAROFF, H., HEWSON, R., and OPSTELTEN, D.J. (1998). Virus maturation by budding. Microbiol. Mol. Biol. Rev. 62, 1171-1190.
11. KARREMAN, S., HAUSER, H., and KARREMAN, C. (1996). On the use of double FLP recognition targets (FRTs) in the LTR of retroviruses for the construction of high producer cell lines. Nucleic Acids Res. 24, 1616-1624.
12. KATZ, R.A., KOTLER, M., and SKALKA, A.M. (1988). Cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: Implication for mechanisms of control. J. Virol. 62, 2686-2695.
13. LE DOUX, J.M., DAVIS, H.E., MORGAN, J.R., and YARMUSH, M.L. (1999). Kinetics of retrovirus production and decay. Biotechnol. Bioeng. 63, 654-662.
14. LEE, S.G., KIM, S., ROBBINS, P.D., and KIM, B.G. (1996). Optimization of environmental factors for the production and handling of recombinant retrovirus. Appl. Microbiol. Biotechnol. 45, 477-483.
15. LEI, P., and ANDREADIS, S.T. (2005). Stoichiometric limitations in assembly of active recombinant retrovirus. Biotechnol. Bioeng. 90, 781-792.
16. MORITA, S., KOJIMA, T., and KITAMURA, T. (2000). Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1066.
17. MOUNTAIN, A. (2000). Gene therapy: The first decade. Trends Biotechnol. 18, 119-128.
18. NAKANO, M., ODAKA, K., TAKAHASHI, Y., ISHIMURA, M., SAITO, I., and KANEGAE, Y. (2005). Production of viral vectors using recombinase-mediated cassette exchange. Nucleic Acids Res. 33, 76-84.
19. OLSEN, J.C., and SECHELSKI, J. (1995). Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum. Gene Ther. 6, 1195-1202.
20. SAMBROOK, J., and RUSSELL, D.W. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
21. SCHLAKE, T., and BODE, J. (1994). Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry 33, 12746-12751.
22. SCHUBELER, D., MAASS, K., and BODE, J. (1998). Retargeting of retroviral integration sites for the predictable expression of transgenes and the analysis of cis-acting sequences. Biochemistry 37, 11907-11914.
23. SCHUCHT, R., COROADINHA, A.S., ZANTA-BOUSSIF, M.A., VERHOEYEN, E., CARRONDO, M.J., HAUSER, H., and WIRTH, D. (2006). A new generation of retroviral producer cells: Predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Mol. Ther. 14, 285-292.
24. SHEN, B.Q., CLARKE, M.F., and PALSSON, B.O. (1996). Kinetics of retroviral production from the amphotropic psiCRIP murine producer cell line. Cytotechnology 22, 185-195.
25. SHERIDAN, P.L., BODNER, M., LYNN, A., PHUONG, T.K., DEPOLO, N.J., DE LA VEGA, D.J., Jr., O'DEA, J., NGUYEN, K., MCCORMACK, J.E., DRIVER, D.A., TOWNSEND, K., IBANEZ, C.E., SAJJADI, N.C., GREENGARD, J.S., MOORE, M.D., RESPESS, J., CHANG, S.M., DUBENSKY, T.W., Jr., JOLLY, D.J., and SAUTER, S.L. (2000). Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: Improved safety and high titer. Mol. Ther. 2, 262-275.
26. SLINGSBY, J.H., BABAN, D., SUTTON, J., ESAPA, M., PRICE, T., KINGSMAN, S.M., KINGSMAN, A.J., and SLADE, A. (2000). Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency. Hum. Gene Ther. 11, 1439-1451.
27. THOMAS, C.E., EHRHARDT, A., and KAY, M.A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4, 346-358.
28. VERHOEYEN, E., HAUSER, H., and WIRTH, D. (2001). Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement. Hum. Gene Ther. 12, 933-944.
29. WESTERMAN, K.A., and LEBOULCH, P. (1996). Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc. Natl. Acad. Sci. U.S.A. 93, 8971-8976.
30. YAP, M.W., KINGSMAN, S.M., and KINGSMAN, A.J. (2000). Effects of stoichiometry of retroviral components on virus production. J. Gen. Virol. 81, 2195-2202.